What is Oramed Pharmaceuticals Inc?
engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 161.33M, and a P/E ratio of 0.9x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.